Advancing research into rare disease

LifeArc has a history of funding rare disease research and since 2019, we have committed more than £30 million.

Now, our commitment to rare diseases is not only continuing, but growing. Our Rare Disease Translational Challenge will see us invest more than £100 million into rare disease research by 2030.

Child in hospital holding parent's hand

Investing in rare disease research

This investment will support the rare disease ecosystem to help bridge the gap between scientific discoveries and patient benefit, tackling some of the major obstacles facing rare disease translational science.

Through fostering innovation and collaboration, we aim to accelerate the pace with which discoveries go on to significantly improve the lives and experience of people living with rare diseases.

About the Rare Disease Translational Challenge
Scientist in LifeArc's Stevenage Lab

Rare disease initiatives to date

LifeArc has been supporting rare disease research since 2017, and we have provided more than £30 million to more than 45 research projects that address over 33 rare disease indications.

These efforts have helped advance knowledge and potential treatments for these often-neglected conditions.

Find details of these initiatives